Predictive Impact of Circulating Vascular Endothelial Growth Factor in Four Phase III Trials Evaluating Bevacizumab
HEGDE, Priti S, JUBB, Adrian M, DAFENG CHEN, LI, Nicole F, GLORIA MENG, Y, BERNAARDS, Coen, ELLIOTT, Rebecca, SCHERER, Stefan J, CHEN, Daniel S
Published in Clinical cancer research (15.02.2013)
Published in Clinical cancer research (15.02.2013)
Get full text
Journal Article
Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response
Breedveld, Ferdinand, Agarwal, Sunil, Yin, Ming, Ren, Song, Li, Nicole F, Shaw, Tim M, Davies, Brian E
Published in Journal of clinical pharmacology (01.09.2007)
Published in Journal of clinical pharmacology (01.09.2007)
Get more information
Journal Article
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trial
Emery, Paul, Fleischmann, Roy, Filipowicz‐Sosnowska, Anna, Schechtman, Joy, Szczepanski, Leszek, Kavanaugh, Arthur, Racewicz, Artur J., van Vollenhoven, Ronald F., Li, Nicole F., Agarwal, Sunil, Hessey, Eva W., Shaw, Timothy M.
Published in Arthritis and rheumatism (01.05.2006)
Published in Arthritis and rheumatism (01.05.2006)
Get full text
Journal Article
A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis
Sher, Lawrence D., McAdoo, Michael A., Bettis, Robert B., Turner, Mark A., Li, Nicole F., Pierce, Phillip F.
Published in Clinical therapeutics (01.02.2002)
Published in Clinical therapeutics (01.02.2002)
Get full text
Journal Article